000 01351 a2200373 4500
005 20250518085431.0
264 0 _c20210329
008 202103s 0 0 eng d
022 _a1096-1186
024 7 _a10.1016/j.phrs.2020.104716
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDianat-Moghadam, Hassan
245 0 0 _aTRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies.
_h[electronic resource]
260 _bPharmacological research
_c05 2020
300 _a104716 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNanomedicine
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aReceptors, TNF-Related Apoptosis-Inducing Ligand
650 0 4 _aRecombinant Proteins
_xmetabolism
650 0 4 _aSignal Transduction
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
_xmetabolism
700 1 _aHeidarifard, Maryam
700 1 _aMahari, Amir
700 1 _aShahgolzari, Mehdi
700 1 _aKeshavarz, Mohsen
700 1 _aNouri, Mohammad
700 1 _aAmoozgar, Zohreh
773 0 _tPharmacological research
_gvol. 155
_gp. 104716
856 4 0 _uhttps://doi.org/10.1016/j.phrs.2020.104716
_zAvailable from publisher's website
999 _c30660402
_d30660402